These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9776280)

  • 1. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
    Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
    J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors.
    Colombo L; Vignati A; Lomuscio G; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
    Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
    Hoefnagel CA; Taal BG; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
    Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
    Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
    Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
    Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
    Taal BG; Hoefnagel CA; Valdes Olmos RA; Boot H; Beijnen JH
    J Clin Oncol; 1996 Jun; 14(6):1829-38. PubMed ID: 8656251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.
    Sywak MS; Pasieka JL; McEwan A; Kline G; Rorstad O
    World J Surg; 2004 Nov; 28(11):1157-62. PubMed ID: 15490060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
    Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
    J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects on radionuclide therapy in malignant pheochromocytomas.
    Forssell-Aronsson E; Bernhardt P; Wängberg B; Kölby L; Nilsson O; Ahlman H
    Ann N Y Acad Sci; 2006 Aug; 1073():498-504. PubMed ID: 17102117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
    Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
    J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
    Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
    Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors.
    Ezziddin S; Sabet A; Logvinski T; Alkawaldeh K; Yong-Hing CJ; Ahmadzadehfar H; Grünwald F; Biersack HJ
    J Nucl Med; 2013 Dec; 54(12):2032-8. PubMed ID: 24101685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.
    Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
    Nuklearmedizin; 2010; 49(1):N2-3. PubMed ID: 20336828
    [No Abstract]   [Full Text] [Related]  

  • 18. Nuclear medicine therapy of neuroblastoma.
    Hoefnagel CA
    Q J Nucl Med; 1999 Dec; 43(4):336-43. PubMed ID: 10731784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in radionuclide therapy].
    Kasagi K; Iwata M; Misaki T; Konishi J; Sakahara H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Nov; 60(13):729-37. PubMed ID: 11140321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
    Garaventa A; Bellagamba O; Lo Piccolo MS; Milanaccio C; Lanino E; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Claudiani F; De Bernardi B
    Br J Cancer; 1999 Dec; 81(8):1378-84. PubMed ID: 10604736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.